Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000219

Director sold 59,441 shares at an average $32.51 ($1,932,665)

  • Director acquired 47,165 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-11 Exercise or conversion : show line 1 in the form 10b5-1 +47,165 $18.00 $848,970 68,661 D
2024-11-11 Sale : show line 2 in the form 10b5-1 −27,129 $32.09 $870,570 41,532 D
2024-11-11 Sale : show line 3 in the form 10b5-1 −32,312 $32.87 $1,062,095 9,220 D
Open-market sales · 59,441 sh · avg $32.51 · $1,932,665

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-11 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −47,165 0 D
Loading xslF345X05/wk-form4_1731532732.xml…